SEC Form 4 · accession 0001179110-15-008140
CymaBay Therapeutics, Inc. · CBAY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Charles McWherter
Officer — Sr. Vice President
Period of report
May 15, 2015
Accepted (ET)
May 19, 2015 · 7:46 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001042074
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 15, 2015 | P | 400 | $3.14 | A | 400 | D | |
| Common Stock | May 15, 2015 | P | 600 | $3.169 | A | 1,000 | D | |
| Common Stock | May 15, 2015 | P | 1,000 | $3.161 | A | 2,000 | D |
Table II — derivative securities
No Table II lines on this filing.